Kelly Blackburn insider trades

Open-market stock purchases and sales by Kelly Blackburn, EVP, Clinical Development at CervoMed Inc, from SEC Form 4 filings since May 6, 2015.

Recent trades

DateStockTradeValue
Feb 11, 2026CRVO CervoMed IncBought (not open market)—

Companies traded

  • CRVO CervoMed Inc: other filings, last Feb 11, 2026
  • LIFE aTYR PHARMA Inc: other filings, last Mar 28, 2016

Get free alerts when Kelly Blackburn files a new trade →